Prosecution Insights
Last updated: May 29, 2026

Examiner: FLINDERS, JEREMY C

Tech Center 1600 • Art Units: 1636 1639 1675 1684

This examiner grants 64% of resolved cases

Performance Statistics

64.3%
Allow Rate
+4.3% vs TC avg
635
Total Applications
+15.5%
Interview Lift
1378
Avg Prosecution Days
Based on 591 resolved cases, 2023–2026

Rejection Statute Breakdown

3.6%
§101 Eligibility
17.0%
§102 Novelty
56.8%
§103 Obviousness
6.5%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17451771 DNA SEQUENCING USING HYDROGEL BEADS Non-Final OA Illumina, Inc.
18653222 Methods of Generating Libraries of Nucleic Acid Sequences for Detection via Fluorescent in Situ Sequencing Final Rejection President and Fellows of Harvard College
18162118 Oligonucleotide Paints Non-Final OA President and Fellows of Harvard College
17791319 COMPOSITIONS AND METHODS FOR DETERMINING PROVENANCE Non-Final OA PRESIDENT AND FELLOWS OF HARVARD COLLEGE
16628348 MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS Final Rejection THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
19323753 METHODS FOR CHARACTERIZING POLYPEPTIDES Final Rejection Nautilus Subsidiary, Inc.
19240418 METHODS OF ASSAYING PROTEINS Final Rejection Nautilus Subsidiary, Inc.
18176062 CRISPR/Cas9 MULTIPLEX KNOCKOUT OF HOST CELL PROTEINS Non-Final OA HOFFMANN-LA ROCHE INC.
18063162 MULTIPLEXED DETECTION WITH ISOTOPE-CODED REPORTERS Non-Final OA Massachusetts Institute of Technology
17695073 STRUCTURED SUBSTRATES FOR OPTICAL SURFACE PROFILING Non-Final OA TRUSTEES OF BOSTON UNIVERSITY
18015990 MATERIALS AND METHODS FOR LOCALIZED DETECTION OF NUCLEIC ACIDS IN A TISSUE SAMPLE Non-Final OA The Regents of the University of Michigan
17997467 COMPOSITIONS AND METHODS FOR IDENTIFICATION OF ZINC FINGERS Non-Final OA New York University
17999619 OLIGONUCLEOTIDE ADAPTERS AND METHOD Non-Final OA Cambridge Enterprise Limited
17784645 High Performance Platform for Combinatorial Genetic Screening Non-Final OA THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
17992727 ANTIGEN DISPLAY SYSTEM AND METHODS FOR CHARACTERIZING ANTIBODY RESPONSES Non-Final OA Duke University
18173551 BIOMARKERS OF IMMUNE DYSFUNCTION IN RESPONSE TO CHRONIC STRESS, METHODS OF USE AND DIAGNOSTIC KITS Non-Final OA The Government of the United States, as Represented by the Secretary of the Army
17583035 SYSTEM AND METHODS FOR DETECTING GENETIC VARIATION Non-Final OA MYRIAD WOMEN'S HEALTH, INC.
17764804 DETERMINISTIC BARCODING FOR SPATIAL OMICS SEQUENCING Final Rejection Yale University
17575094 SURFACE STRUCTURING WITH COLLOIDAL ASSEMBLY Final Rejection Pacific Biosciences of California, Inc.
17758048 Method For Constructing Gene Mutation Library Non-Final OA Nanjing GenScript Biotech Co., Ltd.
17757411 Method For Constructing A Gene Mutation Library Non-Final OA Nanjing GenScript Biotech Co., Ltd.
18304993 REVERSE TRANSCRIPTION OF POLYNUCLEOTIDES COMPRISING UNNATURAL NUCLEOTIDES Non-Final OA The Scripps Research Institute
17715890 LIBRARIES FOR MUTATIONAL ANALYSIS Non-Final OA Twist Bioscience Corporation
18024028 RNA-APTAMER-SENSORS Non-Final OA SenseUp GmbH
17977733 METHODS FOR DETECTING CYSTIC FIBROSIS MUTATIONS USING MITRA TIP EXTRACTION Non-Final OA Quest Diagnostics Investments LLC
17942927 METHODS FOR DETECTING DNA MUTATIONS USING MITRA TIP EXTRACTION Final Rejection Quest Diagnostics Investments LLC
16959578 METHODS FOR FABRICATING HIGH RESOLUTION DNA ARRAY AND ITS APPLICATION IN SEQUENCING Final Rejection CENTRILLION TECHNOLOGY HOLDINGS CORPORATION
16492693 HYDROXYALKYLATED POLYACRYLAMIDE SURFACE COATINGS FOR IN SITU SYNTHESIS OF DNA ARRAYS Final Rejection CENTRILLION TECHNOLOGY HOLDINGS CORPORATION
17759091 HIGH THROUGHPUT LINKING OF MULTIPLE TRANSCRIPTS Non-Final OA ATRECA, INC.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month